Physician

Jeffrey R. Horvath, M.D.

According to 2025 Medicare claims, Jeffrey Horvath, M.D. (NPI: 1588761811) practices rheumatology in the Springfield, IL market, with the plurality of this provider's patient population coming from Sangamon, IL. This provider's primary affiliated billing organization is SPRINGFIELD CLINIC, LLP (NPI: 1780638478; TIN: 370701328) and primary practice location at 62703-2403. Horvath is affiliated with the Springfield Clinic ACO, LLC (ACO ID: A2587), IRCCO (ACO ID: A2619), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Horvath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 462 traditional Medicare patients, billed 59,350 HCPCS/CPT codes, and received $833,028 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,358 prescription claims across 553 beneficiaries totaling $3,814,759 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 24 claims. Open Payments data shows 174 records totaling $34,407. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $728,468 and ending at $833,028. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $588,596 to $3,814,759. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	542	31,251	$728,468
2016	570	33,028	$810,263
2017	568	36,609	$932,361
2018	605	57,284	$1,398,564
2019	664	70,126	$1,406,628
2020	575	75,833	$1,338,312
2021	555	47,878	$1,003,464
2022	513	49,027	$986,820
2023	473	52,183	$1,279,496
2024	462	59,350	$833,028

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	386	3,070	$588,596
2016	372	2,889	$609,967
2017	397	2,762	$629,574
2018	395	2,685	$736,957
2019	444	2,863	$1,025,651
2020	457	2,914	$1,632,758
2021	485	3,091	$1,931,239
2022	515	3,103	$2,382,844
2023	534	3,301	$3,572,208
2024	553	3,358	$3,814,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$601
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	249	491	$86
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	109	186	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	88	112	$13
36415	Insertion of needle into vein for collection of blood sample	199	347	$8
J3489	Injection, zoledronic acid, 1 mg	82	410	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	158	5,214	$1,356,911
Enbrel Sureclick	Etanercept	61	1,764	$465,996
Orencia Clickject	Abatacept	65	2,044	$423,688
Rinvoq	Upadacitinib	60	1,980	$423,209
Enbrel	Etanercept	22	812	$218,570

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	174	$34,407	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey R. Horvath, M.D.?

Tedicare shows public-source Medicare data for Jeffrey R. Horvath, M.D. (NPI 1588761811), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey R. Horvath, M.D. have ACO affiliation data?

Jeffrey R. Horvath, M.D. is shown with ACO affiliation data for Springfield Clinic ACO, LLC (MSSP, ACO ID A2587), IRCCO (MSSP, ACO ID A2619), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jeffrey R. Horvath, M.D.?

Jeffrey R. Horvath, M.D. is linked to SPRINGFIELD CLINIC, LLP (billing NPI 1780638478) in the available physician profile data.

Does Jeffrey R. Horvath, M.D. have Open Payments data?

Jeffrey R. Horvath, M.D. has 174 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.